SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001437749-22-012866
Filing Date
2022-05-18
Accepted
2022-05-18 06:29:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 navb20220517d_posam.htm POS AM 28534
  Complete submission text file 0001437749-22-012866.txt   29630
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-256093 | Film No.: 22936992
SIC: 2835 In Vitro & In Vivo Diagnostic Substances